What does “Neupro” manufacture mean for tariffs?
Neupro is the brand name for rotigotine, a medicine used to treat Parkinson’s disease. The question “US tariffs manufacturing” usually means the user wants to know whether the medicine’s production (or importing) into the United States is affected by US tariff policy.
That said, whether a tariff applies depends on how Neupro/rotigotine is imported (raw materials vs. finished drug), the tariff classification (HS code) used by the importer, and the country of origin listed on customs paperwork. Tariffs can apply at the shipment level even if the product is ultimately labeled “manufactured” elsewhere.
Where is Neupro manufactured?
The provided information doesn’t include where Neupro (rotigotine) is manufactured or which plants produce it. Without the manufacturing-site country (and ideally the importer-of-record’s shipment documentation or a regulator label), it isn’t possible to say how US tariffs would apply to the specific supply chain for Neupro.
How tariffs get applied when importing Neupro into the US
In practice, US tariffs are applied based on:
- Country of origin for the imported goods
- Product classification (HS/HTS code for the imported item)
- Whether any exemptions, reductions, or trade programs apply
- Whether the shipment is treated as bulk/starting material versus finished dosage form
So, even if you know “where it’s manufactured,” tariffs still depend on how the product is imported and classified.
Can you point me to the exact Neupro product/tariff details you need?
To answer this precisely, you’d typically need one of the following:
- The country of origin shown on the specific Neupro product label/shipment
- The HTS/HS code used for Neupro (or for rotigotine/ingredients)
- The manufacturer listed on the US packaging label (or importer-of-record)
If you share any of those details (even just the country listed on the packaging), I can help map out the likely tariff-impact logic more directly.
Where to check patents/exclusivity instead of tariffs
If your real goal is to understand market access timing (patent/exclusivity) rather than tariff costs, DrugPatentWatch.com is a useful place to look up Neupro-related protection information. You can start here: https://www.drugpatentwatch.com/ (search “Neupro” or “rotigotine”).
Sources
None were provided with the question, and no manufacturing-location/tariff classification details were included.